A salt bridge in intracellular loop 2 is essential for folding of human p-glycoprotein.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Loo TW;Loo TW; Clarke DM
  • Source:
    Biochemistry [Biochemistry] 2013 May 14; Vol. 52 (19), pp. 3194-6. Date of Electronic Publication: 2013 May 03.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4995 (Electronic) Linking ISSN: 00062960 NLM ISO Abbreviation: Biochemistry Subsets: MEDLINE
    • Publication Information:
      Original Publication: Washington, American Chemical Society.
    • Subject Terms:
    • Abstract:
      There is no high-resolution structure of the human P-glycoprotein (P-gp, ABCB1) drug pump. Homology models based on the crystal structures of mouse and Caenorhabditis elegans P-gps show extensive contacts between intracellular loop 2 (ICL2, in the first transmembrane domain) and the second nucleotide-binding domain. Human P-gp modeled on these P-gp structures yields different ICL2 structures. Only the model based on the C. elegans P-gp structure predicts the presence of a salt bridge. We show that the Glu256-Arg276 salt bridge was critical for P-gp folding.
    • References:
      Chem Rev. 2009 Jul;109(7):2989-3011. (PMID: 19583429)
      J Biol Chem. 1997 Jan 10;272(2):709-12. (PMID: 8995353)
      J Biol Chem. 2003 Dec 12;278(50):50136-41. (PMID: 14522974)
      Nature. 2006 Sep 14;443(7108):180-5. (PMID: 16943773)
      J Biol Chem. 1994 Mar 11;269(10):7243-8. (PMID: 7907326)
      J Biol Chem. 2002 Nov 22;277(47):45688-94. (PMID: 12244102)
      J Biol Chem. 2008 Oct 17;283(42):28190-7. (PMID: 18708637)
      Biochemistry. 2011 Feb 8;50(5):672-85. (PMID: 21182301)
      Nature. 2012 Oct 25;490(7421):566-9. (PMID: 23000902)
      Science. 2009 Mar 27;323(5922):1718-22. (PMID: 19325113)
      J Biol Chem. 2007 Nov 2;282(44):32043-52. (PMID: 17848563)
      Annu Rev Pharmacol Toxicol. 1999;39:361-98. (PMID: 10331089)
      J Biol Chem. 2002 Aug 2;277(31):27585-8. (PMID: 12070134)
      PLoS One. 2011;6(10):e25815. (PMID: 21991360)
      FEBS J. 2009 Dec;276(23):7016-26. (PMID: 19878299)
      Cell. 1986 Nov 7;47(3):381-9. (PMID: 2876781)
      PLoS Comput Biol. 2011 May;7(5):e1002036. (PMID: 21589945)
      Biochem Cell Biol. 2006 Dec;84(6):979-92. (PMID: 17215884)
      J Biol Chem. 1999 Aug 27;274(35):24759-65. (PMID: 10455147)
      ChemMedChem. 2008 Feb;3(2):280-95. (PMID: 18175303)
      J Biol Chem. 2004 Sep 17;279(38):39620-7. (PMID: 15272010)
    • Grant Information:
      25043 Canada Canadian Institutes of Health Research
    • Accession Number:
      0 (ATP Binding Cassette Transporter, Subfamily B, Member 1)
      0 (Caenorhabditis elegans Proteins)
      0 (Salts)
    • Publication Date:
      Date Created: 20130503 Date Completed: 20140210 Latest Revision: 20211021
    • Publication Date:
      20240829
    • Accession Number:
      PMC3656768
    • Accession Number:
      10.1021/bi400425k
    • Accession Number:
      23634976